To improve the attractiveness and effectiveness of North West London (NWL) as a place to conduct clinical operational research.
This means that:
- There is a simplified process of recruiting patients across NWL into clinical research
- There is a single database for Sarcoid patients, enabling research into a rare condition
- Industry is better supported to understand the research sector in NWL
NWL has an impressive research infrastructure with a BRU,CLAHRC, CRN and AHSC. However researchers and industry alike struggle to access this complex system other than through individual recruiting clinicians who are constrained by capacity. Patients, clinicians and researchers therefore often struggle to find one another, preventing the development of a thriving research ecosystem. Our programme aims to address these issues.
|Rare disease database||
- Clinical institutions collaborate and share patient registrars for mutual benefit
- Industry understands the research sector in NWL
- Patients actively engage with their healthcare, including participating in research targeted specifically at their needs
- Residents and health providers have an active role in clinical research, either through enrolment or study design
- Around 50,000 patients have provided centralised consent to being contacted regarding clinical research
- Research opportunities are capitalised on in NWL in terms of scale and research and development (R&D) income, by improving the ‘recruitment’ process of patients into research